COMMUNIQUÉS West-GlobeNewswire

CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
18/06/2026
BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders (CervoMed or the Company), today announced that it has [...]
Constantiam Biosciences and Cincinnati Children’s Collaborate to Accelerate First-in-Class Neuronopathic Gaucher Disease Therapies
18/06/2026
WATERTOWN, Mass. and CINCINNATI, June 18, 2026 (GLOBE NEWSWIRE) -- Constantiam Biosciences and Cincinnati Children's today announced a strategic collaboration through an exclusive option for future licensing rights to [...]
TestWell Launches Personalized Lab Testing Platform with Custom Test Selection and Physician Integration
18/06/2026
Company Introduces Flexible Direct to Consumer Testing Platform with Custom Panels and Physician Sharing Tools FORT LAUDERDALE, Florida, June 18, 2026 (GLOBE NEWSWIRE) -- TestWell, a direct to consumer laboratory [...]
Medicana Health Group Conducts Pre-World Cup Health Checks for the Türkiye National Football Team
18/06/2026
As the healthcare sponsor of Türkiye’s National Teams since 2024, Medicana Health Group carried out detailed medical screenings for national football players ahead of their World Cup journey to the United States Photo: [...]
PracticeLink Announces Spring 2026 First Practice Fund Scholarship Recipients
18/06/2026
Nine future healthcare providers awarded scholarships to support their transition into practice ST. LOUIS and HINTON, West Virginia, June 18, 2026 (GLOBE NEWSWIRE) -- PracticeLink , the nation’s most trusted physician [...]
Chiesi Global Rare Diseases Highlights Advancements in Lipodystrophy Research at ENDO 2026
18/06/2026
-- Presentations highlight new clinical, real-world, and patient-centered insights on metreleptin across lipodystrophy populations -- BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business [...]
FamilyWell Health Launches Menopause Hub, Setting the Standard for Behavioral Health in Midlife Care
18/06/2026
Program introduces free clinical guidelines for women’s health providers and a comprehensive behavioral health certification for coaches and clinicians BOSTON, June 18, 2026 (GLOBE NEWSWIRE) -- FamilyWell Health , the [...]
SK pharmteco Announces Strategic Collaboration with Orphan Therapeutics Accelerator for the Development and Manufacturing of Rare Disease Therapies
18/06/2026
RANCHO CORDOVA, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- SK pharmteco today announced a collaborative agreement with the Orphan Therapeutics Accelerator (OTXL), a non-profit, biotech focused on completing development [...]
AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer
18/06/2026
Study results expected to support design and initiation of a pivotal Phase 3 clinical trial in the treatment of metastatic pancreatic cancer OCALA, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE [...]
SK pharmteco annonce une collaboration stratégique avec Orphan Therapeutics Accelerator pour le développement et la fabrication de produits thérapeutiques visant les maladies rares
18/06/2026
RANCHO CORDOVA, Californie, 18 juin 2026 (GLOBE NEWSWIRE) -- SK pharmteco annonce ce jour un accord de collaboration avec Orphan Therapeutics Accelerator (OTXL), une organisation à but non lucratif spécialisée dans les [...]
Legend Senior Living Co-CEO Matt Buchanan Named to Senior Housing News' 2026 Executives to Watch List
18/06/2026
WICHITA, Kan., June 18, 2026 (GLOBE NEWSWIRE) -- Legend Senior Living is proud to announce that President and Co-CEO Matt Buchanan has been recognized as one of Senior Housing News' 2026 Executives to Watch , an annual [...]
Daré Bioscience to Showcase Leadership in Women's Health Innovation at BIO International Convention 2026
18/06/2026
President and CEO, Sabrina Martucci Johnson, to participate in featured industry panels and present Company's vision for transforming women's health SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. ( [...]
New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AAIC)
18/06/2026
MIAMI, June 18, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Derm-Biome’s DB-006 Demonstrates Superior Efficacy in Preclinical Atopic Dermatitis Study: Reduces Itch, Inflammation, and IgE Levels, Outperforms Leading Topical Drugs
18/06/2026
VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc., a Vancouver-based biopharmaceutical company focused on skin health and longevity, today announced positive preclinical [...]
BiomX Provides Update on Defense Technology Portfolio and Growth Strategy
18/06/2026
Presentation reflects BiomX’s completed strategic transition and current focus on technologies that identify, analyze, and respond to physical threats NETANYA, Israel, June 18, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE [...]
New Research from Marius Pharmaceuticals Reveals Major Men's Health Awareness Gap: 65% Have Never Had Their Testosterone Levels Tested
18/06/2026
National survey finds many men are experiencing symptoms, delaying medical care, and reporting health concerns that impact work, relationships, and daily life RALEIGH, N.C., June 18, 2026 (GLOBE NEWSWIRE) -- New [...]
NMDP Teams Up with Boozer Brothers to Help More Patients Access Blood Stem Cell Transplants
18/06/2026
The brothers urge young adults to join the NMDP Registry and help save lives by supporting patient access to blood stem cell transplants MINNEAPOLIS, June 18, 2026 (GLOBE NEWSWIRE) -- NMDP, a global nonprofit leader in [...]
Denali Therapeutics Enters Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $195 Million
18/06/2026
Proceeds from transaction to support advancement of Denali’s broad TransportVehicle™-enabled clinical portfolio for lysosomal storage disorders and neurodegenerative diseases Denali was awarded Priority Review Voucher [...]
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
18/06/2026
-- First clinical authorization for an in vivo Prime Editing therapy from Prime Medicine -- -- PM577a targets the H1069Q mutation in the ATP7B gene, the most prevalent WD-causing allele in North America and Europe [...]

Pages